Comparison between Aequs IPO and Capillary Technologies IPO.
Aequs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Capillary Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Aequs IPO is up to ₹921.81 Cr whereas the issue size of the Capillary Technologies IPO is up to ₹877.50 Cr. The final issue price of Aequs IPO is ₹124.00 per share and of Capillary Technologies IPO is ₹577.00 per share.
| Aequs IPO | Capillary Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹118.00 per share | ₹549.00 per share |
| Issue Price (Upper) | ₹124.00 per share | ₹577.00 per share |
| Issue Price (Final) | ₹124.00 per share | ₹577.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹11.00 per share | ₹52.00 per share |
| Market Lot Size | 120 shares | 25 shares |
| Fresh Issue Size | 5,40,47,958 shares | 59,82,635 shares |
| Fresh Issue Size (Amount) | up to ₹670.05 Cr | up to ₹345.12 Cr |
| OFS Issue Size | 2,03,07,393 shares | 92,28,796 shares |
| OFS Issue Size (Amount) | up to ₹251.76 Cr | up to ₹532.38 Cr |
| Issue Size Total | 7,43,55,351 shares | 1,52,11,431 shares |
| Issue Size Total (Amount) | up to ₹921.81 Cr | up to ₹877.50 Cr |
Aequs IPO opens on Dec 03, 2025, while Capillary Technologies IPO opens on Nov 14, 2025. The closing date of Aequs IPO and Capillary Technologies IPO is Dec 05, 2025, and Nov 18, 2025, respectively.
| Aequs IPO | Capillary Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Dec 02, 2025 | Nov 13, 2025 |
| Issue Open | Dec 03, 2025 | Nov 14, 2025 |
| Issue Close | Dec 05, 2025 | Nov 18, 2025 |
| Basis Of Allotment (Tentative) | Dec 08, 2025 | Nov 19, 2025 |
| Initiation of Refunds (Tentative) | Dec 09, 2025 | Nov 20, 2025 |
| Credit of Share (Tentative) | Dec 09, 2025 | Nov 20, 2025 |
| Listing date (Tentative) | Dec 10, 2025 | Nov 21, 2025 |
| Anchor Lockin End date 1 | Jan 06, 2026 | Dec 18, 2025 |
| Anchor Lockin End date 2 | Mar 07, 2026 | Feb 16, 2026 |
Aequs IPO P/E ratio is -74.71, as compared to Capillary Technologies IPO P/E ratio of 298.93.
| Aequs IPO | Capillary Technologies IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Aequs Ltd.'s revenue decreased by 3% and profit after tax (PAT) dropped by 619% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Capillary Technologies India Ltd.'s revenue increased by 14% and profit after tax (PAT) rose by 121% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 64.48 | 67.95 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 59.09 | 52.05 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | -74.71 | 298.93 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹8316.06 Cr. | ₹4576.09 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | -14.30 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 0.87 | 2.76% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.99 | 0.18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹-1.66 | ₹1.93 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -14.47 | 2.85% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aequs IPO Retail Individual Investors (RII) are offered 74,17,835 shares while in Capillary Technologies IPO retail investors are offered 74,17,835 shares. Qualified Institutional Buyers (QIB) are offered 2,22,53,510 shares in Aequs IPO and 45,52,002 shares in Capillary Technologies IPO.
| Aequs IPO | Capillary Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 3,33,80,262 shares | 68,28,001 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 2,22,53,510 shares | 45,52,002 shares |
| NII | 1,11,26,753 shares | 22,76,000 shares |
| RII | 74,17,835 shares | 15,17,333 shares |
| Employee | 1,76,991 shares | 38,095 shares |
| Others | ||
| Total | 7,43,55,351 shares | 1,52,11,431 shares |
Aequs IPO subscribed 104.30x in total, whereas Capillary Technologies IPO subscribed 52.98x.
| Aequs IPO | Capillary Technologies IPO | |
|---|---|---|
| QIB (times) | 122.93x | 57.30x |
| NII (times) | 83.61x | 69.85x |
| Big NII (times) | 79.86x | 85.42x |
| Small NII (times) | 91.13x | 38.72x |
| RII (times) | 81.03x | 15.85x |
| Employee (times) | 37.86x | 6.88x |
| Other (times) | ||
| Total (times) | 104.30x | 52.98x |
